Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lutz Tautz

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
The Journal of Clinical Investigation|July 28, 2015
PTP1B: a new therapeutic target for Rett syndromeLutz Tautz
Expert Opinion on Therapeutic Targets|November 1, 2025
Identification of target sites in the VHR (DUSP3) enzyme unlocking potential avenues for future sepsis treatmentJiaqian Wu, Lutz Tautz
Methods (San Diego, Calif.)|May 29, 2007
Strategies for developing protein tyrosine phosphatase inhibitorsLutz Tautz, Tomas Mustelin
European Journal of Organic Chemistry|February 21, 2012
A highly convergent synthesis of myristoyl-carba(dethia)-coenzyme ALutz Tautz, Janos Rétey
International Journal of Molecular Sciences|March 28, 2026
Phosphatase Signaling as a Therapeutic Strategy in SchizophreniaLauren E Molony, Lutz Tautz
Methods in Molecular Biology (Clifton, N.J.)|July 18, 2013
High-throughput screening for protein tyrosine phosphatase activity modulatorsLutz Tautz, Eduard A Sergienko
Expert Opinion on Therapeutic Targets|January 31, 2006
Targeting the PTPome in human diseaseLutz Tautz, Maurizio Pellecchia, Tomas Mustelin
Biochimica Et Biophysica Acta|April 13, 2007
The lipid-binding SEC14 domainKan Saito, Lutz Tautz, Tomas Mustelin
Journal of Molecular Biology|October 18, 2005
Structure of the hematopoietic tyrosine phosphatase (HePTP) catalytic domain: structure of a KIM phosphatase with phosphate bound at the active siteTomas Mustelin, Lutz Tautz, Rebecca Page
Journal of Molecular Biology|November 25, 2010
Visualizing active-site dynamics in single crystals of HePTP: opening of the WPD loop involves coordinated movement of the E loopDavid A Critton, Lutz Tautz, Rebecca Page
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
The Journal of Clinical Investigation|July 28, 2015
PTP1B: a new therapeutic target for Rett syndromeLutz Tautz
Expert Opinion on Therapeutic Targets|November 1, 2025
Identification of target sites in the VHR (DUSP3) enzyme unlocking potential avenues for future sepsis treatmentJiaqian Wu, Lutz Tautz
Methods (San Diego, Calif.)|May 29, 2007
Strategies for developing protein tyrosine phosphatase inhibitorsLutz Tautz, Tomas Mustelin
European Journal of Organic Chemistry|February 21, 2012
A highly convergent synthesis of myristoyl-carba(dethia)-coenzyme ALutz Tautz, Janos Rétey
International Journal of Molecular Sciences|March 28, 2026
Phosphatase Signaling as a Therapeutic Strategy in SchizophreniaLauren E Molony, Lutz Tautz
Methods in Molecular Biology (Clifton, N.J.)|July 18, 2013
High-throughput screening for protein tyrosine phosphatase activity modulatorsLutz Tautz, Eduard A Sergienko
Expert Opinion on Therapeutic Targets|January 31, 2006
Targeting the PTPome in human diseaseLutz Tautz, Maurizio Pellecchia, Tomas Mustelin
Biochimica Et Biophysica Acta|April 13, 2007
The lipid-binding SEC14 domainKan Saito, Lutz Tautz, Tomas Mustelin
Journal of Molecular Biology|October 18, 2005
Structure of the hematopoietic tyrosine phosphatase (HePTP) catalytic domain: structure of a KIM phosphatase with phosphate bound at the active siteTomas Mustelin, Lutz Tautz, Rebecca Page
Journal of Molecular Biology|November 25, 2010
Visualizing active-site dynamics in single crystals of HePTP: opening of the WPD loop involves coordinated movement of the E loopDavid A Critton, Lutz Tautz, Rebecca Page
Pageof 7